Sleep disturbances in a case of brain-stem lesions; pharmacological study.
Study Design
- Tipo di studio
- Case report
- Dimensione del campione
- 1
- Intervento
- Sleep disturbances in a case of brain-stem lesions; pharmacological study. None
- Comparatore
- Placebo
- Direzione dell'effetto
- Positive
- Rischio di bias
- High
Abstract
A pharmacological study was carried out of a case of severe insomnia following brain-stem lesions; several polygraphic controls were used. Initially total duration of sleep was brief (less than 4 h) with a high REM/NREM ratio and a short paradoxical sleep (PS) latency. In addition, periodic breathing and tremor were observed. Slow injection of delta-sleep-inducing peptide (DSIP) improved sleep both quantitatively and qualitatively, although PS latency remained short. These effects were reversible. The effects of 5-HTP + benzerazide, of L-DOPA + benzerazide (Modopar) and of clonazepam (Rivotril) were compared.
Used In Evidence Reviews
Similar Papers
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2017
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
Annual review of pharmacology and toxicology · 2016
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
Molecular medicine reports · 2010
Chamomile: A herbal medicine of the past with bright future.
Journal of pineal research · 2012
Melatonin and its analogs in insomnia and depression.
Alternative medicine review : a journal of clinical therapeutic · 1998
5-Hydroxytryptophan: a clinically-effective serotonin precursor.
Journal of psychopharmacology (Oxford, England) · 2005